Stanford University researchers have developed a groundbreaking method to generate light deep within living tissues, opening up new possibilities for gene and cancer therapies. This innovative approach utilizes ultrasound to trigger luminescence in nanoscale particles circulating through the bloodstream, marking a significant advancement in medical technology.
The key to this technology lies in the use of ultrasound, which can penetrate tissues more effectively than light waves. Researchers coated nanoparticles with a biocompatible film and suspended them in a solution, which was then injected into the veins of mice. By applying sound waves to different parts of the body, they demonstrated the ability to produce blue light with a wavelength of 490 nm in various organs, including the brain, gut, hindlimb, and spine.
The 490 nm wavelength was chosen for its versatility, as it has applications in neuron modulation and photodynamic cancer therapy. However, the researchers emphasize that this technique can be adapted to various materials, potentially emitting different wavelengths, including ultraviolet light, which possesses antiviral and antibacterial properties.
One of the most exciting implications of this research is its potential to revolutionize gene editing. By combining light-producing nanoparticles with a light-activated gene-editing system, the researchers believe they can use ultrasound to control gene editing in localized areas of the body, addressing the current challenge of off-target effects.
The Stanford team's approach is not limited to gene editing. They are also exploring its integration with other light-activatable control systems, such as photo-switchable Cas9 gene editing, in collaboration with Michael Lin's lab at Stanford. Additionally, they are working on developing safer mechanoluminescent materials that can break down quickly and safely in the body, addressing potential accumulation concerns.
In conclusion, this breakthrough technology has the potential to transform various medical fields, including gene therapy, cancer treatment, and optogenetics. While human trials are still in the future, the researchers' ongoing efforts to refine and expand this approach are promising, bringing us closer to a future where light can be harnessed to treat diseases deep within the body.
